Home
>
US Stocks
>
NovoCure Ltd
NovoCure Ltd
NVCR

NovoCure Ltd

$113.9314.46%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
111.69
Today Low/High
111.69 / 114.38
52 Week Low/High
$76.03 / $232.76
P/E ratio
-3070.4093
Market Cap
$14.03B

Company Details

Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Tumor Treating Fields is a cancer therapy that uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure's commercialized products are approved for the treatment of adult patients with glioblastoma and malignant pleural mesothelioma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and liver cancer.
Organisation
NovoCure Ltd
Headquaters
No 4 Grenville Street, Saint Helier, Jersey
Employees
1.02K
Industry
Health Technology
CEO
Asaf Danziger
Company Financials
  • Annual P&L
  • Quarterly P&L

Discover more

Frequently Asked Questions

What is NovoCure Ltd share price today

Can Indians buy NovoCure Ltd shares?

How can I buy NovoCure Ltd shares from India?

Can Fractional shares of NovoCure Ltd be purchased?

What are the documents required to start investing in NovoCure Ltd stocks?

We are a SEBI registered investement advisor